There were no differences in serum levels of sVEGFR-1, sVEGFR-3, VEGF-C or Ang-2/VEGF ratio between patients with normal ovaries compared to patients with ovarian neoplasms (Table 1, Figure 1E). This evidence concerns the gene ANGPT2 and ovarian neoplasm.